AI Article Synopsis
Article Abstract
Background: Nicotine polacrilex lozenges deliver 25% to 27% more nicotine compared with equivalent doses of nicotine polacrilex gum. The increased nicotine exposure from the lozenge has raised questions about the relative safety of the lozenge and gum.
Objective: The objective of this study was to compare the safety profiles of the 4-mg nicotine lozenge and 4-mg nicotine gum in smokers with selected label-restricted diseases.
Methods: This was a multicenter, randomized, open-label study in adult smokers with heart disease, hypertension not controlled by medication, and/or diabetes mellitus. Patients were randomized in a 1:1 ratio to receive the 4-mg nicotine lozenge or 4-mg nicotine gum. Safety assessments were made at baseline and at 2, 4, 6, and 12 weeks after the start of product use.
Results: Nine hundred one patients were randomized to treatment, 447 who received the lozenge and 454 who received the gum (safety population). The majority were women (52.7%). Patients' mean age was 53.9 years, their mean weight was 193.9 pounds, and they smoked a mean of 25.2 cigarettes per day at baseline. Five hundred fifty-three patients, 264 taking the lozenge and 289 taking the gum, used the study product for > or =4 days per week during the first 2 weeks (evaluable population). The nicotine lozenge and nicotine gum were equally well tolerated, despite increased nicotine exposure from the lozenge. The incidence of adverse events in the 2 groups was similar during the first 2 weeks of product use (evaluation population: 55.3% lozenge, 54.7% gum), as well as during the entire study (safety population: 63.8% and 58.6%, respectively). Stratification of patients by sex, age, extent of concurrent smoking, extent of product use, and severity of adverse events revealed no clinically significant differences between the lozenge and gum. The most common adverse events were nausea (17.2% and 16.1%; 95% CI, -3.7 to 6.0), hiccups (10.7% and 6.6%; 95% CI, 0.5 to 7.8), and headache (8.7% and 9.9%; 95% Cl, -5.0 to 2.6). Serious adverse events were reported in 11 and 13 patients in the respective groups. Fewer than 6% of patients in either group were considered by the investigator to have a worsening of their overall disease condition during the study. The majority of patients (>60%) experienced no change in their disease status from baseline.
Conclusion: The 4-mg nicotine lozenge and 4-mg nicotine gum had comparable safety profiles in these patients with label-restricted medical conditions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clinthera.2005.10.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of the key component puff-by-puff transport in special segments and aerosol for electrical heated tobacco product.
Front Chem
November 2024
Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, China.
Understanding the puff-by-puff delivery mechanisms of key components of heated tobacco products is critical to developing product designs. This study investigates the puff-by-puff release patterns of key components in Natural Smoke Cigarettes (NSCs), which are designed to deliver nicotine without combustion by reducing oxygen content, utilizing a 30-s puff interval, a 2-s puff duration, and a 55 mL puff volume to simulate realistic smoking conditions. By establishing models to analyze the variation of nicotine, glycerol, 1,2-propylene glycol (PG), and water in different functional sections of the cigarette under controlled smoking conditions.
View Article and Find Full Text PDFCharacterization of the nicotine uptake and safety of Nordic spirit tobacco-free oral nicotine pouches: A randomized cross-over study.
Psychopharmacology (Berl)
November 2024
JT International (JTI) SA, 8 Rue Kazem Radjavi, 1202, Geneva, Switzerland.
Article Synopsis
- The study investigates the scientific evaluation of Nordic Spirit nicotine pouches, focusing on their unique composition and how they compare to traditional tobacco products.
- Researchers assessed the blood nicotine delivery, pharmacokinetics, subjective effects, and safety of three different strengths of Nordic Spirit pouches against low-dose tobacco snus and Nicorette gum.
- Results showed that Nordic Spirit NPs delivered nicotine in a dose-dependent manner without significant safety concerns, suggesting their potential for safe human use and further product development.
Characteristics and ingredients of disposable 'Elfbar' e-cigarettes sold in the United States and the United Kingdom.
Addiction
November 2024
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Article Synopsis
- As of 2023, Elfbar is the leading brand of disposable e-cigarettes in the US and UK, with variations in nicotine levels: 5% in the US and 2% in the UK.
- A study tested eight Elfbar devices from both countries, measuring nicotine concentration, aerosol emissions, and flavoring chemicals, finding significant differences in these aspects.
- US Elfbars contained significantly higher nicotine volumes and concentrations, delivering four times more nicotine per puff than UK versions, along with varying types of flavoring chemicals.
Nicotine acute impact on RNFL: a comparative analysis of smoking cessation aids including nicotine gum and electronic cigarettes.
Cutan Ocul Toxicol
December 2024
Optometry Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Purpose: To investigate the immediate impact of nicotine consumption on Retinal Nerve Fiber Layer (RNFL) thickness in healthy young individuals, comparing nicotine gum and electronic cigarette (vaping) as delivery methods.
Materials And Methods: Twenty participants underwent RNFL measurements at baseline, 30, and 60 minutes after consuming 4 mg of nicotine, based on product labeling and specifications. Measurements were obtained using optical coherence tomography (OCT) (Topcon 3D OCT-1 Maestro System).
Acute nicotine exposure attenuates neurological deficits, ischemic injury and brain inflammatory responses and restores hippocampal long-term potentiation in ischemic stroke followed by lipopolysaccharide-induced sepsis-like state.
Exp Neurol
December 2024
Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran. Electronic address:
Ischemic stroke is followed by an increased susceptibility to bacterial infections, which exacerbate histological stroke outcome, neurological deficits and memory impairment due to increased neuroinflammation and neurotransmitter dysfunction. Pharmacological activation of nicotinic acetylcholine receptors was suggested to mitigate brain inflammatory responses in ischemic stroke. The functional responses associated with nicotinic acetylcholine receptor activation were unknown.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!